Movement Disorders
Movement disorder emergencies
Nov. 27, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
04.16.2024
Researchers at the University of Iowa in a new study have linked a region in the brain to how humans redirect thoughts and attention when distracted. The connection is important because it offers insights into cognitive and behavioral side effects to a technique being used to treat patients with Parkinson disease.
The subthalamic nucleus is a pea-sized brain region involved in the motor-control system, meaning our movements. In people with Parkinson disease, those movements have been compromised: Researchers believe the subthalamic nucleus, which normally acts as a brake on sudden movement, is exerting too much influence. That overactive brake, researchers think, is what contributes to the tremors and other motor deficiencies associated with the disease.
In recent years, clinicians have treated Parkinson patients with deep-brain stimulation, an electrode implanted in the subthalamic nucleus that rhythmically generates electrical signals, causing the brain region to loosen its braking, freeing up movement. The deep brain stimulation system is like a pacemaker for the heart; once implanted, it runs continuously.
“The technique is truly miraculous, frankly,” says Jan Wessel, associate professor in the departments of Psychological and Brain Sciences and Neurology at Iowa. “People come in with Parkinson’s, surgeons turn the electrode on, and their tremor goes away. Suddenly they can hold their hands steady and go play golf. It's one of those blockbuster treatments where, when you see it in action, it really makes you believe in what the neuroscience community is doing.”
Yet some patients treated with deep brain stimulation have been beset by an inability to focus attention and impulsive thoughts, sometimes leading to risky behaviors such as gambling and substance use. Researchers began to wonder: Did the subthalamic nucleus’ role in movement also mean this same brain region may deal with thoughts and impulse control?
Wessel decided to find out. His team designed an experiment gauging the focus of attention of more than a dozen patients with Parkinson disease when the deep brain stimulation treatment was either activated or idle. The participants, outfitted with a skull cap to track their brain waves, were instructed to fix their attention on a computer screen while the brain waves in their visual cortex were being monitored. About one in five times, in a random order, the participants heard a chirping sound, meant to divert their visual attention from the screen to the newly introduced audial distraction.
In a 2021 study, Wessel’s group established that brain waves in participants’ visual cortex dropped when they heard a chirp, meaning their attention had been diverted by the sound. By interchanging instances when there was a chirp or no sound, the researchers could see when attention had been diverted, and when the focus of visual attention had been maintained.
The team turned their attention to the Parkinson’s groups for this study. When the deep brain stimulation was idle and the chirp was sounded, the patients with Parkinson disease diverted their attention from the visual to the auditory systems—just as the control group had done in the previous study.
But when the chirp was introduced to the participants with Parkinson with deep brain stimulation activated, those participants did not divert their visual attention.
“We found they no longer can break or suppress their focus of attention in the same way,” says Wessel, the study’s corresponding author. “The unexpected sound happens and they’re still full-on attending to their visual system. They haven’t diverted their attention from the visual.”
The distinction confirmed the subthalamic nucleus’ role in how the brain and body communicate not only with movement—as previously known—but also with thoughts and attention.
“Until now, it was very unclear why those with Parkinson's disease had issues with thoughts, such as why they performed worse on attention tests,” Wessel says. “Our study explains why: While removing the inhibitory influence of the subthalamic nucleus on the motor system is helpful in treating Parkinson’s, removing its inhibitory influence from nonmotor systems (such as thoughts or attention) can have adverse effects.”
Wessel firmly believes deep brain stimulation should continue to be used for patients with Parkinson disease, citing its clear benefits to aiding motor-control functions.
“There may be different areas of the subthalamic nucleus that stop the motor system and that stops the attentional system,” he says. “That's why we're doing the basic research, to find out how do we fine-tune it to get the full benefit to the motor system without accruing any potential side effects.”
The study, “The human subthalamic nucleus transiently inhibits active attentional processes,” was published online March 4 in the journal Brain.
The first author is Cheol Soh, from the Department of Psychological and Brain Sciences at Iowa. Contributing authors, all from Iowa, include Mario Hervault, Nathan H Chalkley, and Cathleen M Moore, from the Department of Psychological and Brain Sciences; Jeremy Greenlee and Andrea Rohl, from the Department of Neurosurgery; and Qiang Zhang and Ergun Uc, from the Department of Neurology.
The National Institutes of Health, and the National Science Foundation, through a CAREER award to Wessel, funded the research.
Source: News Release
University of Iowa
Arpil 15, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125